Stock Screener App

Gratuito -

Installare

1.73

0.57% -0.01

Neumora Therapeutics Inc (NMRA)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché NMRA Giù? Forum Previsione

Neumora Therapeutics Inc Azioni (NMRA) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-06-30	2025-03-31	2024-09-30	2024-06-30	2024-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	23.82% 54.04	70.94	76.65	63.82	60.07
Operating Income/Loss	23.82% -54.04	-70.94	-76.65	-63.82	-60.07
Nonoperating Income/Loss	56.25% 1.334	3.049	4.152	5.247	6.353
Income/Loss From Continuing Operations Before Tax	22.36% -52.71	-67.89	-72.49	-58.58	-53.72
Income Tax Expense/Benefit	76.19% 0.025	0.105	0.053	0.125	-
Income/Loss From Continuing Operations After Tax	22.45% -52.73	-67.99	-72.55	-58.70	-53.72
Net Income/Loss	22.45% -52.73	-67.99	-72.55	-58.70	-53.72
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.15% 161.69	161.45	159.58	158.98	157.94
Diluted Average Shares	0.15% 161.69	161.45	159.58	158.98	157.94
Basic Earnings Per Share	21.43% -0.33	-0.42	-0.45	-0.37	-0.34
Diluted Earnings Per Share	21.43% -0.33	-0.42	-0.45	-0.37	-0.34
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$86.19

0.43%

GMAB

$26.89

3.74%

SMMT

$23.34

1.98%

BNTX

$100.55

0.08%

INSM

$143.04

1.54%

ONC

$337.15

1.60%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters